MaxLinear price target raised to $18 from $11 at Roth Capital

Roth Capital analyst Suji Desilva raised the firm’s price target on MaxLinear (MXL) to $18 from $11 and keeps a Neutral rating on the shares. The company reported and guided revenue ahead of consensus, reflecting recovery and growth driver benefits in core segments. Roth also believes MaxLinear remains on track for strong optical growth this year, and is encouraged by an expected return to operating profitability this quarter, reflecting recent cost restructuring efforts.